期刊文献+

乳腺癌患者外周血CD4^+CD25^+Foxp3^+调节性T细胞水平的检测及意义 被引量:5

Measurement of CD4^+CD25^+Foxp3^+ regulatory T cells in peripheral blood of breast cancer patients and its significance
原文传递
导出
摘要 目的:探讨乳腺癌患者外周血CD4+CD25+Foxp3+调节性T细胞(Treg)水平检测的意义。方法:流式细胞术检测74例乳腺癌患者与30例健康对照者外周血CD4+CD25+Foxp3+Treg占CD4+T细胞百分比,分析CD4+CD25+Foxp3+Treg细胞水平与乳腺癌患者临床病理特征及相关免疫组化指标的关系。结果:乳腺癌患者外周血CD4+CD25+Foxp3+Treg占CD4+T细胞的百分比高于健康对照者[(9.15±2.24)%vs.(2.29±1.36)%],差异有统计学意义(P<0.05)。统计分析显示,乳腺癌患者外周血CD4+CD25+Foxp3+Treg细胞水平与肿瘤组织学分级、淋巴结转移、pTNM分期以及HER-2、pS2、nm23的表达有关(均P<0.05),而与肿瘤大小、病理类型以及雌激素受体(ER)、孕激素受体(PR)、p53、Ki-67表达无关(均P>0.05)。进一步相关性分析显示,CD4+CD25+Foxp3+Treg细胞水平与肿瘤组织学分级、淋巴结转移数、pTNM分期、HER-2的表达呈正相关(r=0.583,r=0.333,r=0.919,r=0.604,均P<0.05)而与pS2、nm23表达呈负相关(r=-0.229,r=-0.401,均P<0.05)。结论:乳腺癌患者外周血CD4+CD25+Foxp3+Treg细胞水平升高,并与与乳腺癌的进展、转移密切相关,对其检测可能有助于患者预后及治疗效果的评估。 Objective: To investigate the value of determination of the peripheral blood level of CD4+CD25+Foxp3+ regulatory T cells (Treg) in breast cancer patients. Methods: The percentage of CD4+CD25+Foxp3+Treg cells in CD4+ T cells in the peripheral blood from 74 breast cancer patients and 30 healthy controls were measured by flow cytometry. The relations of CD4+CD25+Foxp3+Treg cell level with the clinicopathologic factors and relevant immunohistochemical parameters of the breast cancer patients were analyzed. Results: The percentage of CD4+CD25+Foxp3+Treg cells in CD4+ T cells of breast cancer patients was higher than that of healthy controls [(9.15±2.24)% vs. (2.29%±1.36%)], and the difference had statistical significance (P〈0.05). Statistical analyses showed that the peripheral blood level of CD4+CD25+Foxp3+Treg cells of breast cancer patients was significantly related to histological grade, lymph node metastasis, pTNM stage and expressions of HER-2, pS2 and nm23 (r=0.583, r=0.333, r=0.919, r=0.604, all P〈0.05), and irrelevant to tumor size, pathological type and the expressions of estrogen receptor (ER), progesterone receptor (PR), p53 and Ki-67 (all P〉0.05). Further correlation analyses demonstrated that CD4+CD25+Foxp3+Treg cell level was positively correlated with histological grade, number of lymph node metastasis, pTNM stage and Her-2 expression and negatively correlated with pS2 and nm23 expression (r=–0.229, r=-0.401, all P〈0.05). Conclusion: The peripheral blood level of CD4+CD25+Foxp3+Treg cells is increased in breast cancer patients, which also is closely related to the progression and metastasis of breast cancer. So its determination may offer certain implications for evaluation of the prognosis and therapeutic effects of the patients.
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2014年第5期612-617,共6页 China Journal of General Surgery
基金 贵州省教育厅自然科学研究资助项目[黔教科(2009)0110] 教育部新世纪优秀人才计划资助项目(NCET-10-0095)
关键词 乳腺肿瘤 病理学 T淋巴细胞 调节性 叉头转录因子类 Breast Neoplasms/ pathol T-Lymphocytes, Regulatory Forkhead Transcription Factors
  • 相关文献

参考文献20

  • 1唐聃,杨伟明,陆婧,等.调节性T细胞在乳腺癌患者肿瘤免疫的研究进展[J].医药前沿,2013,3(11):104-105.
  • 2Merlo A,Casalini P,Carcangiu ML,et al.FOXP3 expression and overall survival in breast cancer[J].J Clin Oncel,2009,27(11):1746-1753.
  • 3许立生,王水,黄中晶,沈恩超,钱超.CD44^+/CD24^(-/low)/ABCG2^-乳腺癌干细胞与临床治疗及预后的关系[J].实用医学杂志,2011,27(21):3877-3879. 被引量:5
  • 4Hinz S,Pagerols-Raluy L,Oberg HH,et al.Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer[J].Cancer Res,2007,67(17):8344-8350.
  • 5Ebert LM,Tan BS,Browning J,et al.The regulatory T cell-associated transcription factor Foxp3 is expressed by tumor cells[J].Cancer Res,2008,68(8):3001-3009.
  • 6Karanikas V,Speletas M,Zamanakou M,et al.Foxp3 expression in humanm cancer cells[J].J Transl Med,2008,6:19.doi:10.1186/1479-5876-6-19.
  • 7Ziegler SF.Foxp3:not just for regulatory T cells anymore[J].Eur JImmunol,2007,37(1):21-23.
  • 8Sakaguchi S,Yamaguchi T,Nomura T,et al.Regulalory T cells and immune tolerance[J].Cell,2008,133(5):775-787.
  • 9Nair S,Boczkowski D,Fassnacht M,et al.Vaccination against the forkhead family transcrip tion factor Foxp3 enhances tumor immunity[J].Cancer Res,2007,67(1):371-380.
  • 10Ohara M,Yamaquchi Y,Matsuura K,et al.Possible involvement of regulatory T cells in tumor onset and progression in primary breast cancer[J].Cancer Immunol Immunother,2009,58(3):441-447.

二级参考文献37

  • 1刘莉,姚军霞,丁乾,黄士昂.非霍奇金淋巴瘤患者外周血CD4^+CD25^(high)调节性T细胞研究[J].中国实验血液学杂志,2006,14(1):119-122. 被引量:30
  • 2王建,李慧,曹作荣.手术及化疗对卵巢癌患者外周血CD_4^+CD_(25)^+调节性T细胞比例的影响[J].天津医科大学学报,2007,13(2):217-220. 被引量:6
  • 3Maure CA, Grabcr HU, Friess H, et al. Reduced expression of the metastasis suppressor gene KAII in advanced colon cancer and its metastasis [J].Surgery, 1999,126 ( 5 ) :869.
  • 4Elston CW , Ellis IO. The value of histological grade in breast cancer:experience from a large study with long-term follow-up[ J]. Histo- pathology ,2002,41 (3) :151.
  • 5Steeg PS, Bevilacqua G, Kopper L, et al. Evidence for a novel gene associated with a low tumor metastatic potential [J]. J Natl Cancer Inst,1988,80(3) :204.
  • 6Belev B, Alerie I, Vrbanec D, et al. nm23 gene product expression in invasive breast cancer immunohistoehemieal analysis and clinicopathological correlation[ J]. Aeta 0ncol,2002,41 (4) :355-361.
  • 7Kapitanovie S, Cacev T, Berkovic M, et al. nm23-H1 expression and toss of heterozygosity in colon adenoeareinoma[ J]. J Clin Pathol, 2004,57(12) :1312.
  • 8Yaziji H, Goldstein L C, Barry T S, et al. FIER-2 testing in breast cancer using parallel tissue-based methods[J ]. JAMA, 2004, 291: 1972.
  • 9Press M F, Sauter G, Bemstein L, et al. Diagnostic evaluation of HER-2 as a molecular target: an assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trial [ J ]. Clin Cancer Res, 2005, 11 : 6598.
  • 10Dolan M, Snover D. Comparison of immunohistochemical and fluorescence in situ hybridization assessment of HER-2 status in routine practice[J]. Am J Clin Pathol, 2005, 123: 766.

共引文献38

同被引文献41

  • 1俞新爽,韩俊庆,王兴文,盛巍,王瑜.乳腺癌患者细胞免疫水平与预后危险因素的关系及临床意义[J].山东大学学报(医学版),2007,45(9):934-937. 被引量:3
  • 2Ferrone S,Whiteside TL.Tumor microenvironment and immune escape[J].Surg Oncol Clin N Am,2007,16(4):755-774.
  • 3Sakaguchi S,Sakaguchi N,Asano M,et al.Immunologic self-tolerance maintained by activated T cells expressing IL22 receptor α-chains(CD25).Break down of single mechanism of self-tolerance causes various autoimmune disease[J].J Immunol,1995,155(3):1151-1164.
  • 4Ormandy LA,Hillemann T,Wedemeyer H,et al.Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma[J].Cancer Res,2005,65(6):2457-2464.
  • 5Xu T,Duan Q,Wang G,et al.CD4+ CD25high regulatory T cell numbers and FOXP3 mRNA expression in patients with advanced esophageal cancer before and after chemotherapy[J].Cell Biochem Biophys,2011,61(2):389-392.
  • 6Xu H,Mao Y,Dai Y,et al.CD4+ CD25+ regulatory T cells in patients with advanced gastrointestinal cancer treated with chemotherapy[J].Onkologie,2009,32(5):246-252.
  • 7Tokuno K,Hazama S,Yoshino S,et al.In creased prevalence of regulatory T-cells in the peripheral blood of patients with gastrointestinal cancer[J].Anticancer Res,2009,29(5):1527-1532.
  • 8薛磊,徐志飞.转录因子FOXP3在肿瘤免疫中的作用[J].第二军医大学学报,2009,30(9):1077-1080. 被引量:2
  • 9梁建明,钟永,蔡建强,马洁,张叔人.胰腺癌患者外周血CD4^+ CD25^(high)调节性T细胞分析[J].蚌埠医学院学报,2009,34(10):878-879. 被引量:1
  • 10夏雷,王美美.急性高容量血液稀释联合硬膜外阻滞用于妇科肿瘤患者手术32例[J].中国药业,2010,19(1):56-57. 被引量:2

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部